Highlights
Recent News
Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now passed five million...
Nvidia’s Latest Surge Is About More Than a Single Order
Nvidia’s latest rally was not built on a routine earnings beat or a product launch alone. The driver was a...
Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future
When Plug Power releases its second-quarter results after the US market close on Monday, management will face an audience torn...
Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance
The numbers were everything shareholders could have hoped for. The reaction was anything but. Brazil's state-controlled oil giant posted its...
Popular
Net Worth
Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins
Dear readers, Yesterday the debate in Washington was whether the Fed needed to hike again to tame...
Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor
The numbers coming out of Kioxia's first fiscal quarter would be the envy of almost any technology...
French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee
The Cour de cassation, France's highest judicial authority, released a sweeping set of rulings on July 8,...
MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks
The mechanics of benchmark construction rarely make headlines, but a quiet methodological shift at MSCI is about...